Gossamer Bio, Inc. (GOSS)
NMS – Real Time Price. Currency in USD
0.16
-0.01 (-4.96%)
At close: Jun 26, 2026, 4:00 PM EDT
0.16
+0.01 (3.50%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Find any stock by ticker or company name

NMS – Real Time Price. Currency in USD
0.16
-0.01 (-4.96%)
At close: Jun 26, 2026, 4:00 PM EDT
0.16
+0.01 (3.50%)
After-hours: Jun 26, 2026, 7:50 PM EDT
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing seralutinib for the treatment of pulmonary hypertension and pulmonary arterial hypertension in the United States. The company develops GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony-stimulatin factor 1 receptor and c-KIT inhibitor, which is in Phase 3 clinical trial for the treatment of PAH. It has license agreements with Pulmokine, Inc. to develop and commercialize GB002 and related backup compounds. The company was formerly known as FSG, Bio, Inc. and changed its name to Gossamer Bio, Inc. in 2017. The company was incorporated in 2015 and is headquartered in San Diego, California.
| Name | Position |
|---|---|
| Dr. Robert F. Roscigno Ph.D. | Senior Vice President of Clinical Development of Pulmonary Vascular Disease |
| Kelly Dawson | Senior Vice President of Program Team Lead |
| Mr. Bryan Giraudo | COO & CFO |
| Mr. Christian Waage J.D. | EVP & General Counsel |
| Mr. Conor O'Donovan | Senior Vice President of Regulatory Affairs |
| Mr. Faheem Hasnain | Co-Founder, CEO, President & Chairman |
| Mr. Louis K. Cherico | Senior Vice President of Finance & Treasury |
| Mr. Robert Paul Smith Jr. | Chief Commercial Officer |
| Ms. Deanna Weber | Executive Vice President of Human Resources |
| Ms. Jeanine Anthony | Senior Vice President of Marketing |
| Date | Type | Document |
|---|---|---|
| 2026-06-17 | 8-K | goss-20260617.htm |
| 2026-06-09 | DEF 14A | goss-20260609.htm |
| 2026-06-05 | 8-K | goss-20260604.htm |
| 2026-06-02 | 8-K | goss-20260602.htm |
| 2026-05-18 | PRE 14A | goss-20260518.htm |
| 2026-05-18 | DEFA14A | a20260518-gossxdefa14a.htm |
| 2026-05-18 | 8-K | goss-20260518.htm |
| 2026-05-15 | 10-Q | goss-20260331.htm |
| 2026-04-24 | DEFA14A | a20260424-gossxdefa14a.htm |
| 2026-04-24 | DEF 14A | goss-20260423.htm |